EUVIMEDEUVIMED entdecken
Crossref

Evaluating the Safety and Efficacy of Biologics in Oncology

Dr. Sarah Thompson

American Journal Of Pharmacy And Pharmacology · 29.02.2024 · 5 (1) · 1-4

DOI: 10.71465/ajpp.3349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 29.02.2024. Verfasst von Dr. Sarah Thompson.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug delivery across the blood-brain barrier (BBB) remains a significant challenge in the treatment of neurological disorders. Recent advancements in drug delivery systems (DDS) have shown promising potential in overcoming the BBB's selective permeability, enhancing the bioavailability of therapeutic agents in the brain. This article reviews the latest developments in DDS technologies such as nanoparticles, liposomes, and carrier-mediated transport systems, and evaluates their effectiveness in targeting the central nervous system (CNS). The article also discusses the current challenges, safety considerations, and future prospects for integrating DDS into clinical neurology.

Zitieren

APA

Thompson, D. S. (2024). Evaluating the Safety and Efficacy of Biologics in Oncology. American Journal Of Pharmacy And Pharmacology, 5(1), 1-4. https://doi.org/10.71465/ajpp.3349

Vancouver

Thompson DS. Evaluating the Safety and Efficacy of Biologics in Oncology. American Journal Of Pharmacy And Pharmacology. 2024;5(1):1-4. doi:10.71465/ajpp.3349

BibTeX
@article{Thompson2024,
  author = {Thompson, Dr. Sarah},
  title = {Evaluating the Safety and Efficacy of Biologics in Oncology},
  journal = {American Journal Of Pharmacy And Pharmacology},
  year = {2024},
  volume = {5},
  number = {1},
  pages = {1--4},
  doi = {10.71465/ajpp.3349}
}
Kostenlos starten →